Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Age-related changes in grey and white matter structure throughout adulthood.
Giorgio A, Santelli L, Tomassini V, Bosnell R, Smith S, De Stefano N, Johansen-Berg H. Giorgio A, et al. Among authors: tomassini v. Neuroimage. 2010 Jul 1;51(3):943-51. doi: 10.1016/j.neuroimage.2010.03.004. Epub 2010 Mar 6. Neuroimage. 2010. PMID: 20211265 Free PMC article.
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose.
Di Filippo M, Ferraro D, Ragonese P, Prosperini L, Maniscalco GT, Gallo A, Cavalla P, Lorefice L, Nociti V, Di Sabatino E, Clerico M, Guaschino C, Radaelli M, Fantozzi R, Buttari F, Laroni A, Gajofatto A, Calabrese M, Malucchi S, Paolicelli D, De Luca G, Tomassini V, Lanzillo R, Moccia M, Solaro C, Cocco E, Gasperini C, Tortorella C; RIREMS (Rising Researchers in MS) group. Di Filippo M, et al. Among authors: tomassini v. J Neurol. 2024 Jan;271(1):24-31. doi: 10.1007/s00415-023-12034-0. Epub 2023 Nov 3. J Neurol. 2024. PMID: 37922069 Free PMC article.
Lessons from immunotherapies in multiple sclerosis.
Rispoli MG, D'Apolito M, Pozzilli V, Tomassini V. Rispoli MG, et al. Among authors: tomassini v. Handb Clin Neurol. 2023;193:293-311. doi: 10.1016/B978-0-323-85555-6.00013-8. Handb Clin Neurol. 2023. PMID: 36803817 Review.
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients.
Bisecco A, Matrone F, Capobianco M, De Luca G, Filippi M, Granella F, Lus G, Marfia GA, Mirabella M, Patti F, Trojano M, Mascolo A, Copetti M, Tedeschi G, Gallo A; OCREVID study group on behalf of the Italian MS Register. Bisecco A, et al. J Neurol. 2024 Feb;271(2):699-710. doi: 10.1007/s00415-023-12084-4. Epub 2023 Nov 20. J Neurol. 2024. PMID: 37982852 Free PMC article.
Contemporary study of multiple sclerosis disability in South East Wales.
Harding KE, Ingram G, Tallantyre EC, Joseph F, Wardle M, Pickersgill TP, Willis MD, Tomassini V, Pearson OR, Robertson NP. Harding KE, et al. Among authors: tomassini v. J Neurol Neurosurg Psychiatry. 2023 Apr;94(4):272-279. doi: 10.1136/jnnp-2022-330013. Epub 2022 Nov 3. J Neurol Neurosurg Psychiatry. 2023. PMID: 36328420
111 results